Thomas Story & Son LLC Buys 1,805 Shares of Cognex Co. (NASDAQ:CGNX)

Thomas Story & Son LLC increased its holdings in Cognex Co. (NASDAQ:CGNX) by 1.3% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 145,732 shares of the scientific and technical instruments company’s stock after buying an additional 1,805 shares during the quarter. Cognex comprises approximately 2.2% of Thomas Story & Son LLC’s portfolio, making the stock its 20th biggest position. Thomas Story & Son LLC owned about 0.08% of Cognex worth $5,226,000 as of its most recent SEC filing.

Other large investors also recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. grew its stake in shares of Cognex by 9.4% during the 3rd quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,055 shares of the scientific and technical instruments company’s stock valued at $164,000 after purchasing an additional 349 shares during the period. Advisors Asset Management Inc. lifted its position in shares of Cognex by 123.1% during the 3rd quarter. Advisors Asset Management Inc. now owns 714 shares of the scientific and technical instruments company’s stock valued at $29,000 after buying an additional 394 shares in the last quarter. Pacer Advisors Inc. lifted its position in shares of Cognex by 1.7% during the 4th quarter. Pacer Advisors Inc. now owns 25,685 shares of the scientific and technical instruments company’s stock valued at $921,000 after buying an additional 422 shares in the last quarter. First Horizon Advisors Inc. lifted its position in shares of Cognex by 20.1% during the 3rd quarter. First Horizon Advisors Inc. now owns 2,732 shares of the scientific and technical instruments company’s stock valued at $111,000 after buying an additional 457 shares in the last quarter. Finally, Fiduciary Trust Co lifted its position in shares of Cognex by 9.6% during the 3rd quarter. Fiduciary Trust Co now owns 5,443 shares of the scientific and technical instruments company’s stock valued at $220,000 after buying an additional 475 shares in the last quarter. 88.12% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other Cognex news, Director Anthony Sun sold 26,000 shares of the business’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $40.03, for a total transaction of $1,040,780.00. Following the transaction, the director now owns 26,608 shares of the company’s stock, valued at approximately $1,065,118.24. The trade was a 49.42 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CTO Joerg Kuechen sold 2,934 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $37.75, for a total value of $110,758.50. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms recently commented on CGNX. Cantor Fitzgerald raised Cognex to a “strong-buy” rating in a report on Friday, December 20th. Stephens reaffirmed an “overweight” rating and issued a $55.00 price objective on shares of Cognex in a research report on Thursday, January 2nd. Citigroup cut their price target on Cognex from $44.00 to $42.00 and set a “neutral” rating on the stock in a research note on Monday, January 13th. Truist Financial raised their price objective on Cognex from $42.00 to $43.00 and gave the company a “hold” rating in a research report on Thursday, January 16th. Finally, Needham & Company LLC dropped their price objective on Cognex from $50.00 to $47.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. One research analyst has rated the stock with a sell rating, five have issued a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $47.92.

Cognex Price Performance

Cognex stock opened at $38.21 on Monday. Cognex Co. has a 12 month low of $34.98 and a 12 month high of $53.13. The stock has a market capitalization of $6.55 billion, a PE ratio of 73.48 and a beta of 1.40. The business has a 50 day simple moving average of $37.96 and a 200-day simple moving average of $39.35.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.